Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.
Hereditary Angioedema Therapeutic Market contains market size and forecasts of Hereditary Angioedema Therapeutic in Global, including the following market information:
- Global Hereditary Angioedema Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Hereditary Angioedema Therapeutic market was valued at 2149.1 million in 2021 and is projected to reach US$ 3000 million by 2028, at a CAGR of 4.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hereditary Angioedema Therapeutic include BioCryst Pharma, Ionis Pharma, Pharming Group, CSL Limited, Shire, Attune Pharma, Adverum Biotechnologies and KalVista Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hereditary Angioedema Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Angioedema Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Angioedema Therapeutic Market Segment Percentages, by Type, 2021 (%)
- Intravenous
- Subcutaneous
- Oral
Global Hereditary Angioedema Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hereditary Angioedema Therapeutic Market Segment Percentages, by Application, 2021 (%)
Global Hereditary Angioedema Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hereditary Angioedema Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hereditary Angioedema Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Hereditary Angioedema Therapeutic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- BioCryst Pharma
- Ionis Pharma
- Pharming Group
- CSL Limited
- Shire
- Attune Pharma
- Adverum Biotechnologies
- KalVista Pharma
Industry Market Size
